Our Science

Our approach starts with identifying evolutionary T Cell adaptations naturally found within human biology, resulting in increased T Cell proliferation, persistence, and function.

We have developed a suite of proprietary potency enhancement technologies that have the potential to address various challenges that render adoptive T Cell therapy in solid tumors largely ineffective, including poor proliferation and persistence of the infused T cells, T Cell exhaustion, limited T Cell infiltration of the tumor, and the immunosuppressive tumor microenvironment.